-transparent.png){kind=logo}
To achieve the beneficial blood transfusion effect, postoperative immunosuppression with Aza/Pred is mandatory. When CY-A is used for immunosuppression during a limited time, the transfusion effect is not manifested; however CY-A does not lessen the effect in animals given Aza/Pred. In nontransfused recipients, the combination of Aza/Pred and CY-A did not give better graft survival than CY-A alone.
Related Publications
G J Niessen, and
H Obertop, and
A B Bijnen, and
R L Marquet, and
J Jeekel
November 1947,
The Veterinary record,
G J Niessen, and
H Obertop, and
A B Bijnen, and
R L Marquet, and
J Jeekel
January 1984,
Lancet (London, England),
G J Niessen, and
H Obertop, and
A B Bijnen, and
R L Marquet, and
J Jeekel
February 1988,
American journal of diseases of children (1960),
G J Niessen, and
H Obertop, and
A B Bijnen, and
R L Marquet, and
J Jeekel
November 2005,
Transfusion,
G J Niessen, and
H Obertop, and
A B Bijnen, and
R L Marquet, and
J Jeekel
December 1982,
Transplantation proceedings,
G J Niessen, and
H Obertop, and
A B Bijnen, and
R L Marquet, and
J Jeekel
July 1979,
Transplantation,
G J Niessen, and
H Obertop, and
A B Bijnen, and
R L Marquet, and
J Jeekel
October 1969,
Zentralblatt fur Veterinarmedizin. Reihe A,
G J Niessen, and
H Obertop, and
A B Bijnen, and
R L Marquet, and
J Jeekel
January 1989,
Vox sanguinis,
G J Niessen, and
H Obertop, and
A B Bijnen, and
R L Marquet, and
J Jeekel
August 1984,
Lancet (London, England),
G J Niessen, and
H Obertop, and
A B Bijnen, and
R L Marquet, and
J Jeekel
November 1993,
Lancet (London, England),
